TCF7L2基因座:洞察1型和2型糖尿病发病机制的遗传窗口
本文综述了全基因组关联研究(GWAS)在1型和2型糖尿病遗传学中的进展,重点阐述了TCF7L2基因座在2型糖尿病中的核心地位。该基因座被用于探索疾病风险、遗传风险评分、与癌症的遗传共性及糖尿病相关分子通路,并为成人隐匿性自身免疫糖尿病和1型糖尿病的遗传学提供了见解。
要点
- TCF7L2基因座是2型糖尿病GWAS中最突出的易感位点之一
- 该基因座可用于构建遗传风险评分并探索与癌症的遗传共性
- TCF7L2研究为理解1型糖尿病和成人隐匿性自身免疫糖尿病的遗传学提供了线索
核心结论
- TCF7L2基因座是2型糖尿病遗传学研究的核心位点,其研究模式可指导其他基因座的发病机制探索。
研究设计与样本
- 本文为综述,基于过去约15年日益扩大的全基因组关联研究(GWAS)样本,汇总了1型和2型糖尿病的遗传学发现。
主要发现
- GWAS已报道许多与1型和2型糖尿病相关的不同基因座,其中TCF7L2基因座在2型糖尿病研究中占主导地位。
- TCF7L2遗传信号已被用于探索疾病风险、遗传风险评分、与癌症的遗传共性及糖尿病相关分子通路。
- TCF7L2基因座还为成人隐匿性自身免疫糖尿病和多种1型糖尿病表现的遗传学提供了见解。
临床怎么用
- TCF7L2基因座的研究范式可启发临床医生理解遗传风险评分和糖尿病分子分型。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Over the past ∼15 years there has been great progress in our understanding of the genetics of both type 1 diabetes and type 2 diabetes. This has been driven principally by genome-wide association studies (GWAS) in increasingly larger sample sizes, where many distinct loci have now been reported for both traits. One of the loci that dominates these studies is the TCF7L2 locus for type 2 diabetes. This genetic signal has been leveraged to explore multiple aspects of disease risk, including developments in genetic risk scores, genetic commonalities with cancer, and for gaining insights into diabetes-related molecular pathways. Furthermore, the TCF7L2 locus has aided in providing insights into the genetics of both latent autoimmune diabetes in adults and various presentations of type 1 diabetes. This review outlines the knowledge gained to date and highlights how work with this locus leads the way in guiding how many other genetic loci could be similarly used to gain insights into the pathogenesis of diabetes.
引用
- Grant SFA. The TCF7L2 Locus: A Genetic Window Into the Pathogenesis of Type 1 and Type 2 Diabetes. Diabetes Care. 2019. PMID: 31409726. doi:10.2337/dci19-0001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。